Marinus Pharma
(NASDAQ:MRNS)
$9.04
0.19[2.15%]
At close: Mar 28
$9.04
0[0.00%]
After Hours: 4:00PM EDT
Consensus Rating1
Outperform
Highest Price Target1
$28.00
Lowest Price Target1
$9.00
Consensus Price Target1
$20.90

Marinus Pharma Stock (NASDAQ:MRNS), Analyst Ratings, Price Targets, Predictions

Marinus Pharmaceuticals Inc has a consensus price target of $20.9, established from looking at the 33 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Oppenheimer, and RBC Capital on March 26, 2024, March 7, 2024, and March 6, 2024. With an average price target of $20 between HC Wainwright & Co., Oppenheimer, and RBC Capital, there's an implied 121.24% upside for Marinus Pharmaceuticals Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Nov 23
1
Dec 23
1
Mar
3
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Oppenheimer
RBC Capital
Truist Securities
Cantor Fitzgerald

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Marinus Pharma

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/26/2024MRNSBuy Now
Marinus Pharma
$9.04198.67%HC Wainwright & Co.
Douglas Tsao
→ $27ReiteratesBuy → BuyGet Alert
03/07/2024MRNSBuy Now
Marinus Pharma
$9.04-0.44%Oppenheimer
Jay Olson
$9 → $9MaintainsPerformGet Alert
03/06/2024MRNSBuy Now
Marinus Pharma
$9.04165.49%RBC Capital
Brian Abrahams
→ $24ReiteratesOutperform → OutperformGet Alert
03/06/2024MRNSBuy Now
Marinus Pharma
$9.04198.67%HC Wainwright & Co.
Douglas Tsao
→ $27ReiteratesBuy → BuyGet Alert
12/05/2023MRNSBuy Now
Marinus Pharma
$9.04198.67%HC Wainwright & Co.
Douglas Tsao
→ $27ReiteratesBuy → BuyGet Alert
11/08/2023MRNSBuy Now
Marinus Pharma
$9.04176.55%Truist Securities
Joon Lee
$32 → $25MaintainsBuyGet Alert
09/21/2023MRNSBuy Now
Marinus Pharma
$9.04209.73%Cantor Fitzgerald
Charles Duncan
→ $28ReiteratesOverweight → OverweightGet Alert
09/20/2023MRNSBuy Now
Marinus Pharma
$9.04132.3%RBC Capital
Brian Abrahams
$20 → $21MaintainsOutperformGet Alert
09/20/2023MRNSBuy Now
Marinus Pharma
$9.04198.67%HC Wainwright & Co.
Douglas Tsao
→ $27ReiteratesBuy → BuyGet Alert
08/11/2023MRNSBuy Now
Marinus Pharma
$9.04198.67%HC Wainwright & Co.
Douglas Tsao
→ $27ReiteratesBuy → BuyGet Alert
08/11/2023MRNSBuy Now
Marinus Pharma
$9.04121.24%RBC Capital
Brian Abrahams
$21 → $20MaintainsOutperformGet Alert
08/11/2023MRNSBuy Now
Marinus Pharma
$9.04253.98%Truist Securities
Joon Lee
$42 → $32MaintainsBuyGet Alert
08/11/2023MRNSBuy Now
Marinus Pharma
$9.0443.81%Ladenburg Thalmann
Michael Higgins
$17 → $13MaintainsBuyGet Alert
08/11/2023MRNSBuy Now
Marinus Pharma
$9.04121.24%Baird
Brian Skorney
$24 → $20MaintainsOutperformGet Alert
08/11/2023MRNSBuy Now
Marinus Pharma
$9.0454.87%Oppenheimer
Jay Olson
→ $14DowngradeOutperform → PerformGet Alert
06/23/2023MRNSBuy Now
Marinus Pharma
$9.04209.73%Cantor Fitzgerald
Charles Duncan
$28 → $28ReiteratesOverweight → OverweightGet Alert
06/14/2023MRNSBuy Now
Marinus Pharma
$9.04198.67%HC Wainwright & Co.
Douglas Tsao
→ $27ReiteratesBuy → BuyGet Alert
05/30/2023MRNSBuy Now
Marinus Pharma
$9.0499.12%JMP Securities
Jason West
→ $18ReiteratesMarket Outperform → Market OutperformGet Alert
05/12/2023MRNSBuy Now
Marinus Pharma
$9.04364.6%Truist Securities
Joon Lee
$50 → $42MaintainsBuyGet Alert

FAQ

Q

What is the target price for Marinus Pharma (MRNS)?

A

The latest price target for Marinus Pharma (NASDAQ: MRNS) was reported by HC Wainwright & Co. on March 26, 2024. The analyst firm set a price target for $27.00 expecting MRNS to rise to within 12 months (a possible 198.67% upside). 22 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Marinus Pharma (MRNS)?

A

The latest analyst rating for Marinus Pharma (NASDAQ: MRNS) was provided by HC Wainwright & Co., and Marinus Pharma reiterated their buy rating.

Q

When was the last upgrade for Marinus Pharma (MRNS)?

A

There is no last upgrade for Marinus Pharma.

Q

When was the last downgrade for Marinus Pharma (MRNS)?

A

The last downgrade for Marinus Pharmaceuticals Inc happened on August 11, 2023 when Oppenheimer changed their price target from N/A to $14 for Marinus Pharmaceuticals Inc.

Q

When is the next analyst rating going to be posted or updated for Marinus Pharma (MRNS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Marinus Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Marinus Pharma was filed on March 26, 2024 so you should expect the next rating to be made available sometime around March 26, 2025.

Q

Is the Analyst Rating Marinus Pharma (MRNS) correct?

A

While ratings are subjective and will change, the latest Marinus Pharma (MRNS) rating was a reiterated with a price target of $0.00 to $27.00. The current price Marinus Pharma (MRNS) is trading at is $9.04, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch